What is the precise half-life of Nandrolone Decanoate in Decadubol-250 and how was it determined?

The elimination half-life of Nandrolone Decanoate is approximately 6–12 days, characterised in pharmacokinetic studies using HPLC-MS/MS plasma concentration analysis. This wide range reflects interindividual variation in esterase activity and body composition. At 250 mg/ml, a single Decadubol-250 ampoule delivers a dose sufficient to maintain active plasma Nandrolone above detectable thresholds for up to 14 days in most subjects.

How does the Nandrolone Decanoate release profile in Decadubol-250 differ from Nandrolone Phenylpropionate?

Nandrolone Decanoate releases active hormone significantly more slowly than Nandrolone Phenylpropionate. The decanoate ester's ten-carbon chain delays enzymatic hydrolysis, producing a half-life of 6–12 days versus approximately 2.5 days for the phenylpropionate form. This means Decadubol-250 generates a flatter, more sustained plasma concentration curve — requiring less frequent injections and delivering more stable anabolic receptor occupancy between doses.

What injection frequency is pharmacokinetically optimal for Decadubol-250 to maintain steady-state Nandrolone levels?

Pharmacokinetic modelling supports once-weekly or twice-weekly intramuscular injections of Decadubol-250 for steady-state maintenance. Once-weekly dosing leverages the long half-life to sustain trough concentrations above the anabolic threshold, while twice-weekly administration narrows the peak-to-trough ratio by an estimated 30–40 %, offering tighter plasma concentration control for users prioritising hormonal stability.

Why are Decadubol-250 ampoules supplied as 10x1ml single-dose units rather than a multi-dose vial?

Single-dose 1ml ampoules eliminate the sterility risks inherent to repeated needle puncture of multi-dose vials. Each ampoule is hermetically sealed, preventing microbial ingress between uses. BM Pharmaceuticals packages Decadubol-250 in 10-ampoule boxes to support a full cycle duration while ensuring every injection draws from a freshly opened, sterile, single-use container — consistent with EU injectable pharmaceutical standards.

What are the storage requirements for Decadubol-250 ampoules to preserve pharmacokinetic integrity?

Decadubol-250 ampoules should be stored at 15–25 °C, protected from direct light and moisture. The oil-based solution is sensitive to temperature extremes: refrigeration may cause the vehicle oil to cloud or thicken, while excessive heat can degrade ester stability. Ampoules must not be frozen. Once opened, the entire 1ml single-dose unit should be used immediately and any unused portion discarded to maintain sterility. (2) angle_used

Long-Acting Formula

BM Pharmaceuticals

Decadubol-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Name: Decadubol-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals
Brand: BM Pharmaceuticals
SKU: INJ-NAND-BM-250-003
Price: 45.00 EUR
Availability: InStock

Decadubol-250 is a long-chain esterified anabolic injectable in which Nandrolone Decanoate at 250 mg/ml is designed around an extended pharmacokinetic release profile, giving the compound one of the longest circulating half-lives among injectable androgens. The decanoate ester slows hydrolysis after intramuscular depot formation, sustaining active Nandrolone plasma concentrations across a 6–8-day elimination window. Quality assurance is embedded at every production step: HPLC-verified potency, LAL endotoxin screening, and GMP-compliant fill-finish — all carried out by BM Pharmaceuticals.

€45.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Sustained anabolic activity lasting up to 14 days per injection due to the decanoate ester's prolonged hydrolysis rate.
Reduced injection frequency burden — once-weekly administration is pharmacokinetically sufficient for steady-state plasma levels.
Stable hormonal environment between doses, minimising mood and performance fluctuations tied to sharp concentration swings.
Precise 250 mg/ml concentration per 1ml ampoule enables straightforward dose calculation without arithmetic estimation.
Single-dose hermetically sealed ampoules eliminate cross-contamination risk present in multi-dose vial formats.
HPLC-verified potency per lot ensures the declared 250 mg/ml content is analytically confirmed, not estimated.
LAL-tested for bacterial endotoxins, meeting USP <85> and Ph. Eur. 2.6.14 release criteria for injectable products.

Phase	Dosage	Note
Introductory / Pharmacokinetic Loading	200–250 mg once weekly (1 ampoule)	Allows plasma Nandrolone to reach steady-state by weeks 3–4 given the 6–12-day half-life; no front-loading required.
Main Cycle — Weekly Protocol	250–500 mg once weekly (1–2 ampoules)	Once-weekly injection capitalises on the long elimination half-life to maintain trough concentrations above the anabolic threshold throughout the 7-day interval.
Main Cycle — Bi-Weekly Protocol (Tighter Control)	125–250 mg every 3–4 days	Splitting the weekly dose reduces peak-to-trough plasma variability by ~30–40 %; preferred by users sensitive to hormonal fluctuation.
Taper / Cycle Conclusion	200 mg once, final injection 2–3 weeks before PCT start	The 6–12-day half-life necessitates a longer wash-out window before PCT initiation compared to shorter-ester androgens.

Key takeaways

Understand that the decanoate ester delivers a 6–12-day elimination half-life.
Plan injection frequency using pharmacokinetic steady-state modelling — once or twice weekly.
Expect a flat, sustained plasma concentration curve compared to short-ester Nandrolone forms.
Verify potency via HPLC release data confirming 250 mg/ml label claim accuracy.
Store sealed ampoules at room temperature to protect ester and oil vehicle integrity.

Pharmacokinetic Identity of Decadubol-250

Decadubol-250 is an injectable anabolic agent whose therapeutic identity is defined not merely by its active molecule but by the pharmacokinetic architecture the decanoate ester imposes on it: Nandrolone Decanoate at 250 mg/ml forms an intramuscular oil depot from which slow, continuous drug liberation occurs over days rather than hours. The decanoate side chain — a ten-carbon fatty acid — governs the rate of enzymatic ester cleavage, making release kinetics the central pharmacological feature of this formulation.

Half-Life and Plasma Concentration Dynamics

Nandrolone Decanoate carries an elimination half-life of approximately 6–12 days, as established by pharmacokinetic studies using validated HPLC-MS/MS plasma assays. Compared to shorter-ester Nandrolone preparations such as Nandrolone Phenylpropionate (half-life ~2.5 days), Decadubol-250 produces a markedly flatter plasma concentration curve, avoiding the sharp peaks and troughs associated with frequent dosing. This extended half-life means that a single intramuscular injection of Decadubol-250 sustains measurable active Nandrolone above baseline for up to two weeks in most individuals, as documented in clinical pharmacokinetic literature. The oil vehicle — pharmaceutical-grade sesame or arachis oil — further modulates the depot diffusion rate by controlling the viscosity of the injection site matrix.

Injection Frequency Derived from Pharmacokinetics

The half-life data directly informs rational dosing intervals. Clinical convention — supported by pharmacokinetic modelling — positions once-weekly or twice-weekly administration as the optimal strategy for maintaining steady-state plasma Nandrolone concentrations with Decadubol-250. Once-weekly injection cycles reduce administration burden while still achieving trough concentrations sufficient to sustain anabolic receptor occupancy. Twice-weekly protocols reduce inter-dose variability by approximately 30–40 % relative to single weekly administration, offering tighter hormonal control for performance-oriented users.

GMP Manufacturing and Analytical Release Standards

BM Pharmaceuticals subjects every Decadubol-250 lot to a validated analytical release sequence: HPLC quantification confirms that active Nandrolone Decanoate content falls within ±5 % of the declared 250 mg/ml label claim; LAL (Limulus Amebocyte Lysate) testing verifies bacterial endotoxin levels against USP <85> and Ph. Eur. 2.6.14 action limits; and sterility is confirmed by membrane filtration as per Ph. Eur. 2.6.1. Production operates under WHO-GMP guidelines within ISO-classified clean-room environments.

Usage

Calculate your weekly dose based on the 6–12-day half-life: for once-weekly protocols, use 1 full ampoule (250 mg); for twice-weekly, divide the target weekly dose into two equal injections drawn from separate ampoules.
Allow the sealed ampoule to reach room temperature (20–25 °C) before use — cold oil is more viscous, increasing injection resistance and potential injection-site discomfort.
Snap open the ampoule at the scored neck using a standard ampoule opener; inspect the solution for visible particulates or colour change before drawing.
Draw the full 1ml into an appropriately sized syringe using an 18–21G drawing needle; switch to a 23–25G, 1–1.5-inch needle for intramuscular injection into the gluteus medius or vastus lateralis.
Aspirate briefly before depressing the plunger to confirm intravascular placement has been avoided; inject slowly over 10–15 seconds to minimise depot pressure and discomfort.
Discard the used ampoule and needle immediately in a sharps container — the single-dose format means no portion of Decadubol-250 should be stored after opening, preserving the sterility standard each ampoule was sealed to maintain.

Warnings

Contraindications: Decadubol-250 must not be used by individuals with known or suspected androgen-sensitive malignancies (prostate or breast carcinoma), existing hepatic impairment, nephrotic syndrome, or hypercalcaemia. Women who are pregnant or breastfeeding must not use this product. Individuals with a documented hypersensitivity to Nandrolone Decanoate or to the oil vehicle excipient should not administer this preparation.

Side_Effects: Androgenic effects include acne, seborrhoea, and in genetically predisposed individuals accelerated scalp hair thinning. Nandrolone Decanoate suppresses the hypothalamic-pituitary-gonadal (HPG) axis; endogenous testosterone synthesis is significantly reduced during and after the cycle. The compound may adversely shift the lipid profile by lowering HDL cholesterol. Progestin-mediated activity can contribute to gynaecomastia in susceptible users. Water retention and oedema may occur at higher doses.

Monitoring: Haematocrit, haemoglobin, liver enzyme panels (ALT/AST), lipid profile (LDL/HDL ratio), and PSA (in males over 40) should be assessed at baseline and every 8–12 weeks during use. Blood pressure monitoring is recommended throughout the cycle. Due to the 6–12-day half-life, hormone level fluctuations persist for weeks after the last injection — schedule bloodwork accordingly, not immediately post-cycle.

PCT: Because Nandrolone Decanoate's long half-life delays HPG axis recovery, Post-Cycle Therapy (PCT) with a SERM such as Tamoxifen or Clomiphene should not commence until at least 2–3 weeks after the final Decadubol-250 injection — allowing plasma Nandrolone to clear sufficiently. Initiating PCT too early reduces its efficacy. A standard PCT window of 4–6 weeks is typically employed; hCG pre-PCT is advisable if cycle duration exceeded 12 weeks.

Frequently asked questions

What is the precise half-life of Nandrolone Decanoate in Decadubol-250 and how was it determined?: The elimination half-life of Nandrolone Decanoate is approximately 6–12 days, characterised in pharmacokinetic studies using HPLC-MS/MS plasma concentration analysis. This wide range reflects interindividual variation in esterase activity and body composition. At 250 mg/ml, a single Decadubol-250 ampoule delivers a dose sufficient to maintain active plasma Nandrolone above detectable thresholds for up to 14 days in most subjects.
How does the Nandrolone Decanoate release profile in Decadubol-250 differ from Nandrolone Phenylpropionate?: Nandrolone Decanoate releases active hormone significantly more slowly than Nandrolone Phenylpropionate. The decanoate ester's ten-carbon chain delays enzymatic hydrolysis, producing a half-life of 6–12 days versus approximately 2.5 days for the phenylpropionate form. This means Decadubol-250 generates a flatter, more sustained plasma concentration curve — requiring less frequent injections and delivering more stable anabolic receptor occupancy between doses.
What injection frequency is pharmacokinetically optimal for Decadubol-250 to maintain steady-state Nandrolone levels?: Pharmacokinetic modelling supports once-weekly or twice-weekly intramuscular injections of Decadubol-250 for steady-state maintenance. Once-weekly dosing leverages the long half-life to sustain trough concentrations above the anabolic threshold, while twice-weekly administration narrows the peak-to-trough ratio by an estimated 30–40 %, offering tighter plasma concentration control for users prioritising hormonal stability.
Why are Decadubol-250 ampoules supplied as 10x1ml single-dose units rather than a multi-dose vial?: Single-dose 1ml ampoules eliminate the sterility risks inherent to repeated needle puncture of multi-dose vials. Each ampoule is hermetically sealed, preventing microbial ingress between uses. BM Pharmaceuticals packages Decadubol-250 in 10-ampoule boxes to support a full cycle duration while ensuring every injection draws from a freshly opened, sterile, single-use container — consistent with EU injectable pharmaceutical standards.
What are the storage requirements for Decadubol-250 ampoules to preserve pharmacokinetic integrity?: Decadubol-250 ampoules should be stored at 15–25 °C, protected from direct light and moisture. The oil-based solution is sensitive to temperature extremes: refrigeration may cause the vehicle oil to cloud or thicken, while excessive heat can degrade ester stability. Ampoules must not be frozen. Once opened, the entire 1ml single-dose unit should be used immediately and any unused portion discarded to maintain sterility. (2) angle_used

Manufacturer

BM Pharmaceuticals has built its distribution infrastructure around maintaining cold-chain integrity and regulatory documentation traceability from production release to end-point delivery. Each batch of Decadubol-250 is assigned a unique lot number tied to a full Certificate of Analysis (CoA) — covering HPLC potency data, LAL endotoxin results, and sterility test outcomes per Ph. Eur. 2.6.1 — which travels with the shipment throughout the logistics chain. The company's export-oriented distribution model is structured to comply with import documentation requirements across multiple international jurisdictions, ensuring that customs clearance processes are supported by complete GMP-certification records. Secondary packaging for Decadubol-250 ampoules incorporates tamper-evident sealing verified at dispatch, providing an unbroken audit trail from the fill-finish suite to the customer's point of receipt.

Product details

Brand	BM Pharmaceuticals
Active ingredient	nandrolone decanoate
Also known as	Deca Durabolin, Deca, Nandrolone Decanoate, Decadubol-250, BM Pharmaceuticals Deca Durabolin
Strength	250 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-NAND-BM-250-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Decandrol 200mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Decandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Decandrol is an injectable anabolic steroid produced by Balkan Pharmaceuticals, delivering Nandrolone Decanoate at 200 mg per millilitre across a ten-ampoule pack — a formulation directly rooted in over six decades of pharmaceutical and clinical development of the nandrolone molecule. First synthesised in 1960, Nandrolone Decanoate evolved from early research compounds into one of the most studied anabolics in sports medicine and endocrinology literature. Quality assurance at the Chișinău facility is governed by GMP compliance, with each production batch subjected to HPLC potency verification and LAL endotoxin testing before release.

€44.00

High Concentration

Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Beligas Pharmaceuticals Deca-Durabolin delivers 300 mg of Nandrolone Decanoate per millilitre in a 10 ml multi-dose vial, purpose-engineered for integration into structured, periodised cycle protocols where consistent anabolic stimulus and joint support are programmed across distinct training phases. At 300 mg/ml, each vial provides 3,000 mg of active compound — enough to sustain a full intermediate-length cycle from kickstart to planned taper without mid-cycle restocking. Quality assurance is baked into every stage of production: HPLC-verified potency, LAL endotoxin testing on each batch, and full-cycle GMP compliance underpin the consistency that modern cycle planners demand.

€52.00

Trusted Brand

DecaTrex 350mg/ml 10ml Vial by Concentrex Labs

DecaTrex by Concentrex Labs delivers Nandrolone Decanoate at 350 mg/ml in a 10 ml multi-dose vial, purpose-built for athletes who structure their year around defined cruise and blast phases rather than standalone cycles. Its elevated concentration minimises injection volume during high-dose blast windows while keeping weekly cruise doses manageable with a single, low-volume pull. Every production batch passes HPLC quantification for concentration accuracy and LAL endotoxin testing for sterility assurance; GMP-certified manufacturing protocols govern each step from API weighing through final vial sealing.

€52.00

Pro Choice

Deca 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Deca 300 delivers Nandrolone Decanoate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically to support the hormonal and musculoskeletal needs common in aging men and medically supervised TRT programs. Its decanoate ester provides a stable, prolonged anabolic environment that complements low-testosterone management without the sharp concentration swings associated with shorter esters. Quality assurance is built into every batch: HPLC-verified concentration, LAL endotoxin testing, and GMP-compliant production at Dragon-Pharma's registered facilities.

€46.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00